VANGUARD GROUP INC 13D and 13G filings for Xeris Biopharma Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-27 2:12 pm Sale | 2026-03-13 | 13G | XERIS BIOPHARMA HLDGS INC XERS | VANGUARD GROUP INC | 0 0.000% | -11,186,677 (Position Closed) | Filing |
| 2026-01-30 2:43 pm Purchase | 2025-12-31 | 13G | XERIS BIOPHARMA HLDGS INC XERS | VANGUARD GROUP INC | 11,186,677 6.740% | 4,100,332 (+57.86%) | Filing |
| 2024-02-13 5:17 pm Purchase | 2023-12-29 | 13G | XERIS BIOPHARMA HLDGS INC XERS | VANGUARD GROUP INC | 7,086,345 5.130% | 7,086,345 (New Position) | Filing |